Pricing Log in Create free account
Saturday 17 October 2026 Export ALC’s income statement to Excel — free account

Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

66.18 0.40 −0.60%
Market cap
$32.1B
P/E
50.5×
Fwd P/E
31.0×
Dividend yield
0.53%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Alcon (ALC) Business Profile

Updated before January 2025

Company Overview

Alcon (ALC) is a global leader in eye care, dedicated to helping people see brilliantly. The company was originally founded in 1945 in Fort Worth, Texas, by pharmacists Robert Alexander and William Conner. Initially, Alcon focused on ophthalmic products and quickly gained recognition for its innovative solutions in eye care. Over the decades, the company expanded its portfolio and global presence, becoming a trusted name in the industry. In 2019, Alcon became an independent, publicly traded company after spinning off from Novartis, a leading pharmaceutical company. Alcon is headquartered in Geneva, Switzerland, and Fort Worth, Texas, and operates in over 70 countries, serving customers in more than 140 markets worldwide.

Alcon’s leadership team is composed of experienced professionals with a deep understanding of the healthcare and medical device industries. David J. Endicott serves as the Chief Executive Officer (CEO), bringing years of expertise in global healthcare management. The company’s leadership is committed to innovation, sustainability, and delivering high-quality products and services to improve vision care globally.

Core Business Segments

Alcon operates through two primary business segments: Surgical and Vision Care. These segments encompass a wide range of products and services designed to address various eye care needs.

1. Surgical

The Surgical segment focuses on products and technologies used in ophthalmic surgery. This includes:

  • Cataract Surgery Products: Alcon offers advanced intraocular lenses (IOLs) such as the AcrySof® IQ PanOptix® Trifocal IOL, which provides patients with improved vision at multiple distances. The company also provides surgical equipment like the Centurion® Vision System, which enhances precision and efficiency during cataract procedures.
  • Refractive Surgery Products: Alcon provides laser systems like the WaveLight® Refractive Suite, designed for LASIK and other vision correction procedures.
  • Vitreoretinal Surgery Products: Alcon offers tools and devices for treating retinal disorders, including the CONSTELLATION® Vision System and a range of surgical instruments.

2. Vision Care

The Vision Care segment focuses on non-surgical solutions for vision correction and eye health. Key offerings include:

  • Contact Lenses: Alcon is a leading provider of contact lenses, including the DAILIES® and AIR OPTIX® brands. These lenses cater to various needs, such as daily disposable and extended wear options.
  • Ocular Health Products: Alcon offers a range of over-the-counter products, including artificial tears like Systane® for dry eye relief and solutions for contact lens care.

Business Model

Alcon’s business model revolves around integrating innovative products and services to address the full spectrum of eye care needs. The company invests heavily in research and development (R&D) to create cutting-edge technologies and solutions. Alcon generates revenue through the sale of its surgical equipment, intraocular lenses, contact lenses, and ocular health products. Additionally, the company provides training and support to healthcare professionals, ensuring the effective use of its products.

Alcon’s global distribution network and partnerships with eye care professionals enable it to reach a broad customer base. The company’s focus on quality, innovation, and customer satisfaction has solidified its position as a leader in the eye care industry.

Strategic Direction

Alcon is committed to advancing eye care through innovation and sustainability. The company’s strategic priorities include:

  • Expanding Product Portfolio: Alcon aims to introduce new products and technologies to address unmet needs in eye care. This includes developing advanced intraocular lenses, contact lenses, and surgical equipment.
  • Sustainability Goals: Alcon is focused on reducing its environmental footprint by adopting sustainable practices in manufacturing and packaging. The company is also committed to improving access to eye care in underserved communities.
  • Digital Transformation: Alcon is leveraging digital technologies to enhance customer experiences and streamline operations. This includes the use of data analytics and artificial intelligence to improve product development and customer support.
  • Geographic Expansion: Alcon is working to strengthen its presence in emerging markets, where the demand for eye care solutions is growing rapidly.

Competitive Landscape

Alcon operates in a highly competitive industry, facing competition from both large multinational corporations and smaller specialized companies. Key competitors include:

  • Johnson & Johnson Vision: A major player in the eye care industry, offering a wide range of surgical and vision care products.
  • Bausch + Lomb: Known for its contact lenses, surgical equipment, and ocular health products.
  • Carl Zeiss Meditec: Specializes in ophthalmic surgical equipment and diagnostic tools.
  • CooperVision: A leading provider of contact lenses and related products.

Despite the competition, Alcon’s strong brand reputation, innovative product portfolio, and global reach give it a competitive edge.

Risk Factors

Alcon faces several risks that could impact its business operations and financial performance. Key risks include:

  • Market Dependence: Alcon’s revenue is heavily dependent on the sales of its surgical and vision care products. Any decline in demand for these products could adversely affect the company.
  • Supply Chain Disruptions: The global supply chain challenges, including shortages of raw materials and transportation issues, could impact Alcon’s ability to deliver products on time.
  • Regulatory Compliance: As a healthcare company, Alcon must comply with stringent regulations in various markets. Non-compliance could result in fines, product recalls, or reputational damage.
  • Economic Conditions: Economic downturns or changes in healthcare policies could affect consumer spending on eye care products and services.

Recent Developments

Alcon has made significant strides in innovation and corporate strategy in recent years. Notable developments include:

  • New Product Launches: Alcon recently introduced the PRECISION1® contact lenses, designed for first-time wearers seeking comfort and convenience.
  • Acquisitions: The company has acquired several smaller firms to enhance its product portfolio and expand its market presence.
  • Sustainability Initiatives: Alcon has implemented eco-friendly practices, such as reducing plastic waste in its packaging and adopting energy-efficient manufacturing processes.
  • Global Events: The COVID-19 pandemic impacted Alcon’s operations, particularly in the surgical segment, as elective procedures were postponed. However, the company has since recovered and is experiencing strong demand for its products.

Investment Considerations

Investors considering Alcon should weigh the following strengths and risks:

Strengths

  • Market Leadership: Alcon is a global leader in eye care, with a strong brand and extensive product portfolio.
  • Innovation: The company’s focus on R&D ensures a steady pipeline of new products and technologies.
  • Global Reach: Alcon’s presence in over 140 markets provides significant growth opportunities.

Risks

  • Market Dependence: Heavy reliance on specific product categories could pose risks if market conditions change.
  • Regulatory Challenges: Compliance with healthcare regulations is complex and costly.
  • Economic Sensitivity: Changes in economic conditions or healthcare policies could impact demand for Alcon’s products.

Conclusion

Alcon is a leading player in the eye care industry, known for its innovative products and commitment to improving vision care worldwide. The company’s strong market position, focus on sustainability, and strategic initiatives position it for long-term growth. While challenges such as market dependence and regulatory compliance exist, Alcon’s strengths make it a compelling choice for investors and a trusted partner for eye care professionals.